CD4 and myeloid sarcoma: DICAM was initially associated with BBB-related astrocytes in the CNS [104], but in MS patients, an increased frequency of DICAM+ CD4+ T cells in the peripheral blood and increased expression of its ligands, DICAM and αvβ3 integrin, were observed on endothelial cells in CNS lesions [102].